Emerging Opportunities for Target Discovery in Rare Cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging Opportunities for Target Discovery in Rare Cancers

Published:2017-09 Issue:9 Volume:24 Page:1075-1091
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Sharifnia Tanaz,Hong Andrew L.,Painter Corrie A.,Boehm Jesse S.

Funder

The Katie Moore Fund

Chordoma Foundation

CureSearch for Children's Cancer

Alex's Lemonade Stand Foundation for Childhood Cancer

National Cancer Institute

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference185 articles.

1. National Cancer Institute's Precision Medicine Initiatives for the new National Clinical Trials Network;Abrams;Am. Soc. Clin. Oncol. Educ. Book,2014

2. Nasopharyngeal adenoid cystic carcinoma, a rare but highly challenging disease with unmet therapeutic needs: a case-report and review of the literature;Afani;Cancer Radiother.,2016

3. Genomic copy number dictates a gene-independent cell response to CRISPR/Cas9 targeting;Aguirre;Cancer Discov.,2016

4. Cell line misidentification: the beginning of the end;American Type Culture Collection Standards Development Organization Workgroup ASN-0002;Nat. Rev. Cancer,2010

5. Management and retrospective analysis of primary and metastatic sacral tumors and infections: evaluation with 73 cases;Arıkan;Eklem Hastalik Cerrahisi,2014

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Head and Neck Sarcoma Assessor (HaNSA) for treatment decisions using real-world data;ESMO Real World Data and Digital Oncology;2024-09

2. Patientenabgeleitete 3-D-Tumormodelle;Die Onkologie;2024-06-11

3. Low-Dose Sorafenib Promotes Cancer Stem Cell Expansion and Accelerated Tumor Progression in Soft Tissue Sarcomas;International Journal of Molecular Sciences;2024-03-15

4. Disentangling trust of patients with rare cancer in their healthcare professionals and the healthcare system: a qualitative interview study;Journal of Cancer Survivorship;2024-01-16

5. Recent advancement in pyrrolidine moiety for the management of cancer: A review;Results in Chemistry;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3